GRADE: an Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations_Chinese Journal of Evidence-Based Medicine

Authors：

Gordon H Guyatt , Andrew D Oxman , Gunn E Vist , Regina Kunz , Yngve FalckYtter , Pablo AlonsoCoello , Holger J Schunemann , 代表GRADE工作组

Corresponding author：

Keywords：

DOI：

10.7507/1672-2531.20090005

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： Gordon H Guyatt,Andrew D Oxman,Gunn E Vist,Regina Kunz,Yngve FalckYtter,Pablo AlonsoCoello,Holger J Schunemann,代表GRADE工作组. GRADE: an Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations. Chinese Journal of Evidence-Based Medicine, 2009, 09(1): 8-11. doi: 10.7507/1672-2531.20090005 Copy

1.	Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res, 2004, 4(1): 38.
2.	Lacchetti C, Guyatt G. Surprising results of randomized trials. In: Guyatt G, Drummond R, eds. Users’ guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
3.	American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med, 1992, 117(12): 1038-1041.
4.	Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med, 2002, 137(4): 273-284.
5.	Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 1998, 280(7): 605-613.
6.	Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002, 288(3): 321-333.
7.	Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med, 1991, 324(12): 781-788.
8.	Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA, 1992, 268(2): 240-248.
9.	Committee on Infectious Diseases. Aspirin and Reye syndrome. Pediatrics, 1982, 69(6): 810-812.

1. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res, 2004, 4(1): 38.
2. Lacchetti C, Guyatt G. Surprising results of randomized trials. In: Guyatt G, Drummond R, eds. Users’ guides to the medical literature: a manual of evidence-based clinical practice. Chicago, IL: AMA Press, 2002.
3. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med, 1992, 117(12): 1038-1041.
4. Humphrey LL, Chan BK, Sox HC. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann Intern Med, 2002, 137(4): 273-284.
5. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA, 1998, 280(7): 605-613.
6. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA, 2002, 288(3): 321-333.
7. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med, 1991, 324(12): 781-788.
8. Antman EM, Lau J, Kupelnick B, et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA, 1992, 268(2): 240-248.
9. Committee on Infectious Diseases. Aspirin and Reye syndrome. Pediatrics, 1982, 69(6): 810-812.

Previous Article
右中叶肺癌术后合并急性呼吸窘迫综合征救治体会
Next Article
卡泊芬净治疗IgA肾病并发肺孢子菌肺炎一例

Chinese Journal of Evidence-Based Medicine

GRADE: an Emerging Consensus on Rating Quality of Evidence and Strength of Recommendations

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content